PDD Posts Upbeat Revenue, Joins Avidity Biosciences, SpringWorks Therapeutics And Other Big Stocks Moving Higher On Tuesday

Comments
Loading...

U.S. stocks traded mixed, with the Dow Jones gaining around 10 points on Tuesday.

Shares of PDD Holdings Inc. PDD jumped in Tuesday’s session following third-quarter results.
PDD reported third-quarter FY23 revenue growth of 94% year-on-year to $9.44 billion, beating the consensus of $7.69 billion.The Chinese online retailer's adjusted earnings per ADS of RMB11.61 ($1.55), compared with RMB8.62 Y/Y, beating the consensus of $1.23.

PDD Holdings shares jumped 18.6% to $139.62 on Tuesday.

Here are some other big stocks recording gains in today’s session.

  • Avidity Biosciences, Inc. RNA surged 22.3% to $7.53 after the company reported expansion of cardiovascular collaboration with Bristol Myers Squibb.
  • SpringWorks Therapeutics, Inc. SWTX gained 15.5% to $23.99. The FDA approved SpringWorks Therapeutics’ Ogsiveo (nirogacestat), an oral gamma-secretase inhibitor, for adult patients with progressing desmoid tumors who require systemic treatment.
  • GDEV Inc. GDEV surged 10% to $2.53. The company recently reported a decline in third-quarter sales.
  • nLIGHT, Inc. LASR gained 8% to $13.98. Benchmark upgraded nLight from Hold to Speculative Buy and announced a $17 price target.
  • Clearway Energy, Inc. CWEN gained 7.4% to $24.55. Clearway Energy will replace Veritiv in the S&P SmallCap 600.
  • The Carlyle Group Inc. CG rose 6% to $34.78. Carlyle Group will replace ICU Medical in the S&P MidCap 400, effective prior to the open of trading on Nov. 30.
  • LendingClub Corporation LC gained 5.4% to $5.88. Piper Sandler initiated coverage on LendingClub with an Overweight rating and announced a price target of $8.

 

Now Read This: Boeing To Rally More Than 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!